These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 1532243

  • 1. Oncogenic activation of murine mos protein kinase by DNA rearrangement of its N-terminal coding region.
    Ohuchi T, Kurita Y, Sasai H, Miyoshi J, Nomura T, Toyoshima K.
    Oncogene; 1992 Feb; 7(2):331-8. PubMed ID: 1532243
    [Abstract] [Full Text] [Related]

  • 2. Activation of c-mos oncogene by integration of an endogenous long terminal repeat element during transfection of genomic DNA from mouse skin tumor cells.
    Wang S, Nishigori C, Miyakoshi J, Tsukada T, Shung B, Yagi T, Takebe H.
    Oncogene; 1993 Apr; 8(4):1009-16. PubMed ID: 8455928
    [Abstract] [Full Text] [Related]

  • 3. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A, Thraves PJ, Dritschilo A, Notario V.
    Oncogene; 1996 Oct 17; 13(8):1755-63. PubMed ID: 8895522
    [Abstract] [Full Text] [Related]

  • 4. Characterization of activated and normal mouse Mos gene in murine 3T3 cells.
    Paules RS, Resnick J, Kasenally AB, Ernst MK, Donovan P, Vande Woude GF.
    Oncogene; 1992 Dec 17; 7(12):2489-98. PubMed ID: 1461652
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evidence for somatic cell expression of the c-mos protein [corrected].
    Herzog NK, Ramagli LS, Khorana S, Arlinghaus RB.
    Oncogene; 1989 Nov 17; 4(11):1307-15. PubMed ID: 2530484
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mutagenic analysis of functional domains of the mos proto-oncogene and identification of the sites important for MAPK activation and DNA binding.
    Fukasawa K, Zhou R, Matten WT, Armstrong AJ, Daar I, Oskarsson M, Sathyanarayana BK, Maclvor L, Wood TG, Vande Woude GF.
    Oncogene; 1995 Oct 19; 11(8):1447-57. PubMed ID: 7478569
    [Abstract] [Full Text] [Related]

  • 12. Human hst-2 (FGF-6) oncogene: cDNA cloning and characterization.
    Iida S, Yoshida T, Naito K, Sakamoto H, Katoh O, Hirohashi S, Sato T, Onda M, Sugimura T, Terada M.
    Oncogene; 1992 Feb 19; 7(2):303-9. PubMed ID: 1549352
    [Abstract] [Full Text] [Related]

  • 13. The human met oncogene is a member of the tyrosine kinase family.
    Gonzatti-Haces M, Park M, Dean M, Blair DG, Vande Woude GF.
    Princess Takamatsu Symp; 1986 Feb 19; 17():221-32. PubMed ID: 3332011
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. cph, a novel oncogene which cooperates with H-ras in the transformation of NIH3T3 fibroblasts.
    Velasco JA, Castro R, Avila MA, Laborda J, DiPaolo JA, Cansado J, Notario V.
    Oncogene; 1994 Jul 19; 9(7):2065-9. PubMed ID: 8208552
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of structure and activation of some receptor-type tyrosine kinase oncogenes.
    Shibuya M, Matsushime H, Yamazaki H, Wang LH, Fukui Y, Ueyama Y, Tamaoki N.
    Princess Takamatsu Symp; 1986 Jul 19; 17():195-202. PubMed ID: 3455414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.